Literature DB >> 19389220

Complications of plasma exchange in patients treated for thrombotic thrombocytopenic purpura. IV. An additional study of 43 consecutive patients, 2005 to 2008.

Loan Nguyen, Deirdra R Terrell, Deanna Duvall, Sara K Vesely, James N George.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19389220     DOI： 10.1111/j.1537-2995.2008.02030.x

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  9 in total

1.  Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011.

Authors:  Sumit Som; Cassandra C Deford; Mandi L Kaiser; Deirdra R Terrell; Johanna A Kremer Hovinga; Bernhard Lämmle; James N George; Sara K Vesely
Journal:  Transfusion       Date:  2012-04-15       Impact factor: 3.157

Review 2.  Thrombotic thrombocytopenic purpura: recognition and management.

Authors:  Joseph E Kiss
Journal:  Int J Hematol       Date:  2010-01       Impact factor: 2.490

3.  Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?

Authors:  Sonata Jodele; Benjamin L Laskin; Jens Goebel; Jane C Khoury; Susan L Pinkard; Patricia M Carey; Stella M Davies
Journal:  Transfusion       Date:  2012-07-15       Impact factor: 3.157

Review 4.  Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies.

Authors:  J Khosla; A C Yeh; T R Spitzer; B R Dey
Journal:  Bone Marrow Transplant       Date:  2017-10-02       Impact factor: 5.483

5.  Systemic infections mimicking thrombotic thrombocytopenic purpura.

Authors:  Kristina K Booth; Deirdra R Terrell; Sara K Vesely; James N George
Journal:  Am J Hematol       Date:  2011-09       Impact factor: 10.047

6.  Complete recovery of ischemic cardiomyopathy from thrombotic thrombocytopenic purpura.

Authors:  Sainath Gaddam; Lata Pablani; Vinod Chainani; Ravi Raj Kavuda; Tarun Nagrani; Georges Abou Rjaili; Meekoo Dhar; James C Lafferty
Journal:  Clin Med Insights Cardiol       Date:  2011-03-14

7.  Predictive features of chronic kidney disease in atypical haemolytic uremic syndrome.

Authors:  Matthieu Jamme; Quentin Raimbourg; Dominique Chauveau; Amélie Seguin; Claire Presne; Pierre Perez; Pierre Gobert; Alain Wynckel; François Provôt; Yahsou Delmas; Christiane Mousson; Aude Servais; Laurence Vrigneaud; Agnès Veyradier; Eric Rondeau; Paul Coppo
Journal:  PLoS One       Date:  2017-05-18       Impact factor: 3.240

8.  Efficacy and safety of open-label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study.

Authors:  Paul Knoebl; Spero Cataland; Flora Peyvandi; Paul Coppo; Marie Scully; Johanna A Kremer Hovinga; Ara Metjian; Javier de la Rubia; Katerina Pavenski; Jessica Minkue Mi Edou; Hilde De Winter; Filip Callewaert
Journal:  J Thromb Haemost       Date:  2019-12-09       Impact factor: 5.824

Review 9.  Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: A Review Based on Physiopathology.

Authors:  Giuseppe Milone; Claudia Bellofiore; Salvatore Leotta; Giulio Antonio Milone; Alessandra Cupri; Andrea Duminuco; Bruno Garibaldi; Giuseppe Palumbo
Journal:  J Clin Med       Date:  2022-01-26       Impact factor: 4.241
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.